Given that robust proliferation and activation of antitumor Tc is integral to tumor eradication induced by Sirpα−/− macrophages and local RT, implementing PD-L1 blockade into this combination may significantly enhance the efficacy of Sirpα−/− macrophage-based antitumor treatments. Here, SIRPA is linked to neoplasm.